NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NPCE is expected to report earnings to rise 35.22% to -24 cents per share on May 08
Q1'25
Est.
$-0.24
Q4'24
Beat
by $0.07
Q3'24
Beat
by $0.08
Q2'24
Beat
by $0.04
Q1'24
Est.
$-0.32
The last earnings report on March 04 showed earnings per share of -18 cents, beating the estimate of -25 cents. With 103.05K shares outstanding, the current market capitalization sits at 385.20M.